Clinical and Regulatory Perspectives on Biosimilar Therapies and Intended Copies of Biologics in Rheumatology

Rheumatology International - Germany
doi 10.1007/s00296-016-3444-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Anti-TNF Therapies and Pregnancy: Outcome of 130 Pregnancies in the British Society for Rheumatology Biologics Register

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2011English

Regulatory and Clinical Experiences With Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada

Oncologist
Cancer ResearchMedicineOncology
2019English

Similar Biologics: Regulatory Prospective in India

Journal of Pharmaceutical Research
2017English

Development Pathways for Subcutaneous Formulations of Biologics Versus Biosimilar Development

Expert Review of Precision Medicine and Drug Development
Molecular MedicineDrug DiscoveryGeneticsPharmacology
2019English

Trends in List Prices, Net Prices, and Discounts for Originator Biologics Facing Biosimilar Competition

JAMA network open
Medicine
2019English

New Perspectives in Rheumatology: Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti-Dna

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

New Era of Treatment With Biologics in Rheumatology – Is It Time to Shift Paradigms in Treatment With Biologics?

Reumatologia
RheumatologyAllergyImmunology
2019English

FDA Biosimilar Action Plan: Could Improving Pharmacovigilance of Biologics Improve Patient and Physician Confidence in Biosimilars?

Expert Opinion on Drug Safety
MedicinePharmacology
2020English

Psy157 - Emerging Rheumatoid Arthritis and Psoriasis Biologics: How to Thrive in the Face of Biosimilar Competition?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy